22nd-May-2013 13:38Source: BSE

Ajanta Pharma- Re: Date of Annual General Meeting (AGM on July 26, 2013)

With reference to the earlier announcement dated April 30, 2013 wherein the Company has inadvertently informed that the Annual General Meeting of the Company would be held on July 13, 2013, Ajanta Pha...

21st-May-2013 17:55Source: NSE

Ajanta Pharma Limited

Ajanta Pharma Limited has informed the Exchange that the date of payment of dividend on equity shares would be on after July 26, 2013, subject to approval of the shareholders at the forthcoming Annual...

21st-May-2013 15:36Source: BSE

Ajanta Pharma- Fixes Book Closure for Dividend & AGM

Ajanta Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 22, 2013 to July 26, 2013 (both days inclusive) for the purpose of Pa...

21st-May-2013 15:26Source: NSE

Ajanta Pharma Limited

Ajanta Pharma Limited has informed the Exchange that Mr. Rajesh M. Agrawal and Mr. K H Viswanathan have been appointed as Additional Directors w.e.f. April 30, 2013.Further, Mr. Rajesh M. Agrawal is a...

21st-May-2013 15:25Source: BSE

Ajanta Pharma- Change in Directorate

Ajanta Pharma Ltd has informed BSE that Mr. Rajesh M. Agrawal and Mr. K H Viswanathan have been appointed as Additional Directors w.e.f. April 30, 2013.

Further, Mr. Rajesh M. Agrawal is appoin...

16th-May-2013 12:47Source: NSE

Ajanta Pharma Limited

Gabs Investments Private Limited has submitted to the Exchange, vide letter dated May 09, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regul...

15th-May-2013 12:52Source: NSE

Ajanta Pharma Limited

Gabs Investments Pvt ltd has submitted to the Exchange vide its letter dated May 07, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation...

13th-May-2013 14:45Source: BSE

Ajanta Pharma- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Gabs Investments Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

11th-May-2013 15:06Source: BSE

Ajanta Pharma- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Gabs Investments Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

10th-May-2013 18:10Source: NSE

Ajanta Pharma Limited

Aayush Madhusudan Agrawal has submitted to the Exchange vide its letter dated May 07, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulatio...